You just read:

BioMarin to Provide Update to Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A at 35th Annual J.P. Morgan Healthcare Conference

News provided by

BioMarin Pharmaceutical Inc.

08 Jan, 2017, 19:45 ET